OBIO

Orchestra BioMed Holdings, Inc. NASDAQ Listed Aug 4, 2020

Healthcare ·Biotechnology ·US · orchestrabiomed.com

$3.93

Mkt Cap $230.0M

52w Low $2.20 53.7% of range 52w High $5.42

50d MA $4.34 200d MA $3.79

P/E (TTM) -3.6x

EV/EBITDA -3094.3x

P/B 2335.3x

Debt/Equity 0.0x

ROE -52.8%

P/FCF -3221.9x

RSI (14) —

ATR (14) —

Beta 0.60

50d MA $4.34

200d MA $3.79

Avg Volume 204.0K

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

SIC Code

3841

CIK (SEC)

1814114

Phone

215 862 5797

150 Union Square Drive · New Hope, PA 18938 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 8, 2026	BMO	—	—	—	3.93	+1.5%	+2.8%	—	—	—	—	—
Mar 12, 2026	AMC	-0.38	0.26	+168.4%	4.38	+0.0%	-4.1%	+3.9%	+5.3%	+3.0%	+5.9%	—
Nov 10, 2025	AMC	-0.38	-0.40	-5.3%	3.78	-0.8%	+8.5%	+16.9%	+10.6%	+4.2%	+9.3%	—
Aug 12, 2025	AMC	-0.51	-0.50	+2.0%	2.72	-0.7%	-2.2%	-2.2%	-5.5%	-3.3%	-6.2%	—
Apr 2, 2025	AMC	-0.43	-0.43	+0.0%	3.52	-8.8%	-11.6%	-21.6%	-19.6%	-20.7%	-16.8%	—
Mar 26, 2025	AMC	-0.43	-0.37	+14.0%	4.38	+4.1%	+5.0%	+0.5%	-2.3%	-26.0%	-19.6%	—
Nov 12, 2024	AMC	-0.44	-0.41	+6.8%	5.66	+5.8%	+7.2%	+9.7%	+3.2%	+3.0%	-8.7%	—
Aug 12, 2024	AMC	-0.41	-0.45	-9.8%	6.11	+2.3%	-2.5%	-9.3%	-0.8%	+5.1%	+4.6%	—
May 13, 2024	AMC	-0.40	-0.38	+5.0%	4.60	+0.0%	+13.0%	+4.6%	+0.4%	+13.3%	+13.7%	—
Mar 27, 2024	AMC	-0.38	-0.37	+2.6%	5.31	-1.3%	-0.8%	-6.8%	-5.1%	-7.7%	-6.4%	—
Nov 13, 2023	AMC	-0.39	-0.38	+2.6%	6.04	-4.0%	+13.1%	+17.9%	+15.6%	+12.4%	+11.6%	—
Aug 10, 2023	AMC	-0.42	-0.35	+16.7%	6.07	+1.6%	-1.6%	-3.3%	-7.1%	-12.0%	-9.9%	—
May 12, 2023	AMC	-0.28	-0.40	-42.9%	17.00	+2.8%	+2.5%	-0.3%	+15.3%	-6.6%	-10.8%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 12	Chardan Capital	Maintains	Buy → Buy	—	$4.60	$4.61	+0.2%	-4.8%	-8.7%	-1.1%	+0.2%	-2.0%
Jan 9	Barclays	Maintains	Overweight → Overweight	—	$4.84	$4.96	+2.5%	-0.8%	-3.7%	-11.6%	-7.9%	-13.8%
Nov 13	Chardan Capital	Maintains	Buy → Buy	—	$4.42	$4.38	-0.9%	-5.4%	-10.9%	-6.6%	-4.3%	+5.4%
Nov 12	Barclays	Maintains	Overweight → Overweight	—	$4.10	$4.17	+1.7%	+7.8%	+2.0%	-3.9%	+0.7%	+3.2%
Sep 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.72	$2.73	+0.4%	+0.7%	+1.1%	+0.4%	-0.4%	-4.0%
Aug 20	BTIG	Downgrade	Buy → Neutral	—	$2.55	$2.56	+0.4%	-4.7%	-2.4%	+0.0%	+2.0%	+17.6%
Aug 13	Chardan Capital	Maintains	Buy → Buy	—	$2.72	$2.70	-0.7%	-2.2%	-2.2%	-5.5%	-3.3%	-6.2%
Aug 7	Chardan Capital	Maintains	Buy → Buy	—	$2.64	$2.68	+1.5%	-1.5%	+2.7%	-4.5%	+3.0%	+0.8%
May 13	Chardan Capital	Maintains	Buy → Buy	—	$2.65	$2.72	+2.6%	+10.9%	+6.4%	+9.1%	+9.4%	+10.2%
May 5	Barclays	Maintains	Overweight → Overweight	—	$2.74	$2.66	-2.9%	-6.6%	-11.7%	-10.2%	+4.7%	-3.3%
Apr 22	Chardan Capital	Maintains	Buy → Buy	—	$2.84	$3.13	+10.2%	+0.7%	+0.4%	-9.2%	-2.1%	-8.1%
Apr 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.11	$2.96	-4.8%	-11.3%	-9.0%	-10.3%	-5.8%	-16.4%
Apr 1	Chardan Capital	Maintains	Buy → Buy	—	$4.28	$3.86	-9.8%	-24.3%	-17.8%	-27.3%	-35.5%	-33.9%
Mar 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.23	$4.16	-1.7%	-6.1%	-5.4%	-5.0%	-9.2%	-3.5%
Nov 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.21	$6.25	+0.6%	-6.0%	-6.1%	-16.7%	-15.0%	-12.4%
Nov 13	Chardan Capital	Maintains	Buy → Buy	—	$5.66	$5.99	+5.8%	+7.2%	+9.7%	+3.2%	+3.0%	-8.7%
Jun 12	Chardan Capital	Maintains	Buy → Buy	—	$7.96	$8.14	+2.3%	-0.3%	-1.8%	+0.1%	+1.0%	-6.5%
Mar 28	Chardan Capital	Maintains	Buy → Buy	—	$5.31	$5.24	-1.3%	-0.8%	-6.8%	-5.1%	-7.7%	-6.4%
Aug 11	Chardan Capital	Maintains	Buy → Buy	—	$6.07	$6.17	+1.6%	-1.6%	-3.3%	-7.1%	-12.0%	-9.9%
Aug 9	Chardan Capital	Maintains	Buy → Buy	—	$5.54	$5.79	+4.5%	+2.3%	+9.6%	+7.8%	+6.0%	+1.8%
May 15	Chardan Capital	Maintains	Buy → Buy	—	$17.00	$17.47	+2.8%	+2.5%	-0.3%	+15.3%	-6.6%	-10.8%

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
Apr 27, 2026	RTW INVESTMENTS, LP	—	Sell	32	$4.13	$132	9,556,063	+5.00%	+8.16%

Data updated apr 26, 2026 4:46pm · Source: massive.com